- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a target name.
BioCentury | Dec 17, 2019
Financial News
Cellestia plans Phase II for solid, blood cancers with $20M series B
BioCentury | Jan 18, 2018
Translation in Brief
A notch for tankyrase
NYU paper identifies new cancer opportunities for tankyrase inhibitors
BioCentury | May 11, 2017
Tools & Techniques
Stemming the tide
Why OncoMed’s failure might not be death knell for cancer stem cells
BioCentury | Apr 7, 2017
Emerging Company Profile
Up a notch
Why Cellestia Notch inhibitors could work in more patients than competitors’ do
BioCentury | Sep 22, 2016
Distillery Therapeutics
Therapeutics: Notch signaling pathway; hairy and enhancer of split1 (HES1)
BioCentury | Mar 3, 2016
Translation in Brief
Notching up differences
A new wrinkle for Notch in melanoma
Items per page:
1 - 10 of 26